FDA clears Xenix Medical’s Lux fusion system

▤ Summary

Xenix Medical has won FDA clearance for its Lux expandable lumbar interbody fusion system and launched it in the US. The device is built for spinal fusion surgery and aims to improve procedural success while giving surgeons more flexibility. Xenix says Lux uses NeoWave matrix spacer implants and NanoActiv surface technology to support bone growth and reduce subsidence risk. The company also points to demand for expandable interbody fusion devices and highlights Lux’s fit for PLIF and TLIF procedures. This clearance follows another recent FDA approval for Xenix’s Riva posterior fixation system, showing continued product expansion.

▦ Linked Companies